Cited by 796Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.

New insights into the pharmacodynamic and pharmacokinetic properties of statins

Corsini, Alberto, Bellosta, Stefano, Baetta, Roberta, Fumagalli, Remo, Paoletti, Rodolfo, Bernini, Franco·1999·Pharmacology & Therapeutics

DOI 10.1016/s0163-7258(99)00045-5

Open this paper in CoChat — free account

Abstract

The beneficial effects of statins are assumed to result from their ability to reduce cholesterol biosynthesis. However, because mevalonic acid is the precursor not only of cholesterol, but also of many nonsteroidal isoprenoid compounds, inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase may result in pleiotropic effects. It has been shown that several statins decrease smooth muscle cell migration and proliferation and that sera from fluvastatin-treated patients interfere with its proliferation. Cholesterol accumulation in macrophages can be inhibited by different statins, while both fluvastatin and simvastatin inhibit secretion of metalloproteinases by human monocyte-derived macrophages. The antiatherosclerotic effects of statins may be achieved by modifying hypercholesterolemia and the arterial wall environment as well. Although statins rarely have severe adverse effects, interactions with other drugs deserve attention. Simvastatin, lovastatin, cerivastatin, and atorvastatin are biotransformed in the liver primarily by cytochrome P450-3A4, and are susceptible to drug interactions when co-administered with potential inhibitors of this enzyme. Indeed, pharmacokinetic interactions (e.g., increased bioavailability), myositis, and rhabdomyolysis have been reported following concurrent use of simvastatin or lovastatin and cyclosporine A, mibefradil, or nefazodone. In contrast, fluvastatin (mainly metabolized by cytochrome P450-2C9) and pravastatin (eliminated by other metabolic routes) are less subject to this interaction. Nevertheless, a 5- to 23-fold increase in pravastatin bioavailability has been reported in the presence of cyclosporine A. In summary, statins may have direct effects on the arterial wall, which may contribute to their antiatherosclerotic actions. Furthermore, some statins may have lower adverse drug interaction potential than others, which is an important determinant of safety during long-term therapy.

Integrity signals

Registry

Crossref · 10.1016/s0163-7258(99)00045-5

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 9,216
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Coronary Plaque Disruption
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 2,018

Show all 186 references

Research works printed but not linked: 8

Fischer, 1999, The HMG-CoA reductase inhibitor fluvastatin, Drug Metab Dispos, 27, 410
Henwood, 1995, Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia, Drugs, 31, 9
Hoffman, 1992, The interaction of lovastatin and warfarin, Conn Med, 56, 107
Mai, 1997, Clinical pharmacokinetics of a new HMG-CoA reductase inhibitor in renal transplant patients treated with cyclosporin A (CSA), Eur J Clin Pharmacol, 52, A137
Raiteri, 1997, Pharmacological control of the mevalonate pathway, J Pharmacol Exp Ther, 281, 1144
1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease, Lancet, 344, 1383
Smith, 1991, HMG-CoA reductase inhibitor-induced myopathy in the rat, J Pharmacol Exp Ther, 257, 1225
Soma, 1995, In vitro and in vivo enhanced anti-tumor activity of carmustine (BCNU) by simvastatin, a hypocholesterolemic drug, Cancer Res, 55, 597

Sorted by citations

Items 501–600 of 794

Microextraction based on liquid-solid phase transition of benzoic acid: Extraction of statins from human urine followed by chromatographic analysis
Manousi, N., Tzanavaras, P. D., & Zacharis, C. K. (2023) · Talanta · doi:10.1016/j.talanta.2023.125088 · Cited by 11
Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation
Baetta, R., Lento, S., Ghilardi, S., Barbati, E., Corsini, A., Tremoli, E., & Banfi, C. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2014.11.008 · Cited by 11
Self-citation
Atorvastatin: a review of its pharmacological properties and use in familial hypercholesterolemia
Haque, T., & Khan, B. V. (2010) · Clinical Lipidology · doi:10.2217/clp.10.55 · Cited by 11
Aearly-onset rhabdomyolysis in a patient with nephrotic syndrome
José, J., Saravu, K., & Shastry, B. A. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060241 · Cited by 11
Considerations in the Treatment of Dyslipidemia Associated With Chronic Kidney Failure and Renal Transplantation
Davidson, M. H. (2005) · Preventive Cardiology · doi:10.1111/j.0197-3118.2005.04078.x · Cited by 11
Combined Organ Failure with Combination Antihyperlipidemic Treatment: A Case of Hepatic Injury and Acute Renal Failure
Akoğlu, H., Yılmaz, R., Kırkpantur, A., Arıcı, M., Altun, B., & Turgan, Ç. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h251 · Cited by 11
Optimization of Culture Conditions for the Production of Lovastatin by Aspergillus Terreus in Submerged Fermentation
Azeem, M., Saleem, Y., Hussain, Z., Zahoor, S., & Javed, M. M. (2018) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-018-1807-4 · Cited by 12
Simultaneous production of natural statins and coenzyme Q10 by Monascus pilosus fermentation using different solid substrates
Pyo, Y.-H., & Seo, S.-Y. (2010) · Food Science and Biotechnology · doi:10.1007/s10068-010-0231-7 · Cited by 11
The significance of genetic polymorphisms in modulating the response to lipid-lowering drugs
Hoffmann, M. M., Winkelmann, B. R., Wieland, H., & März, W. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.2.107 · Cited by 11
Cerivastatin: a cellular and molecular drug for the future?
Siegel-Axel, D. I. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s000180300010 · Cited by 11
Statins: balancing benefits, efficacy and safety
Clearfield, M. B. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.5.469 · Cited by 11
Self-micellizing solid dispersion of atorvastatin with improved physicochemical stability and oral absorption
Banik, S., Sato, H., & Onoue, S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.103065 · Cited by 10
Utilization of a nanostructured lipid carrier encapsulating pitavastatin– Pinus densiflora oil for enhancing cytotoxicity against the gingival carcinoma HGF-1 cell line
Felimban, R. I., Tayeb, H. H., Chaudhary, A., Felemban, M., Alnadwi, F. H., Ali, S. A., Alblowi, J. A., Alfayez, E., Bukhary, D. M., Alissa, M., et al. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2155269 · Cited by 10
Simvastatin modulates mouse embryonic stem cell-derived chondrogenesis in vitro
Kramer, J., Bartsch, M. V., Krug, D. A., Klinger, M. H. F., Nitschke, M., & Rohwedel, J. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.06.013 · Cited by 10
Manipulation of Lipid Rafts in Neuronal Cells
Eckert, G. P. (2010) · The Open Biology Journal · doi:10.2174/18741967010030100032 · Cited by 10
Effects of atorvastatin on plasma matrix metalloproteinase-9 concentration after glial tumor resection; a randomized, double blind, placebo controlled trial
Mohebbi, N., Khoshnevisan, A., Naderi, S., Abdollahzade, S., Salamzadeh, J., Javadi, M., Mojtahedzadeh, M., & Gholami, K. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-22-10 · Cited by 10
Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence
Prado, Y., Aravena, D., Llancalahuén, F. M., Aravena, C., Eltit, F., Echeverría, C., Gatica, S., Riedel, C. A., & Simón, F. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-26163-3_2 · Cited by 10
Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder
Zaid, A. N., Assali, M., Zalmout, S., & Basheer, A. (2016) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2016-000913 · Cited by 9
Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?
Tatham, L. M., Liptrott, N. J., Rannard, S. P., & Owen, A. (2019) · Molecules · doi:10.3390/molecules24152685 · Cited by 9
Statins mediate anti- and pro-tumourigenic functions by remodelling the tumour microenvironment
Kamata, T., Aldujaily, E., Alhamad, S., So, T. Y., Margaritaki, O., Giblett, S. M., Pringle, J. H., Quesne, J. P. C. L., & Pritchard, C. A. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049148 · Cited by 9
Expression of OATP2B1 as determinant of drug effects in the microcompartment of the coronary artery
Hußner, J., Begunk, R., Boettcher, K., Gliesche, D. G., Prestin, K., & zu Schwabedissen, H. E. M. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.06.006 · Cited by 9
Fluvastatin in the Treatment of Dyslipidemia Associated with Chronic Kidney Failure and Renal Transplantation
Corsini, A., & Holdaas, H. (2005) · Renal Failure · doi:10.1081/jdi-200056623 · Cited by 9
Self-citation
Genetic basis for developmental toxicity due to statin intake using embryonic stem cell differentiation model
Jyoti, S., & Tandon, S. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327114564795 · Cited by 9
Interacciones farmacológicas de las estatinas
Gutiérrez, J. M. Á., Hidalgo, J. D. L.-T., Blesa, P. G., Ruiz, E. M. G., & de Mora, F. N. (2003) · Atención Primaria · doi:10.1016/s0212-6567(03)79163-x · Cited by 9
Cerivastatin monotherapy-induced muscle weakness, rhabdomyolysis and acute renal failure
Bakri, R. S., Wang, J., Wierzbicki, A. S., & Goldsmith, D. J. A. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00581-8 · Cited by 9
Effect of Atorvastatin on ApoE and ApoC-I Synthesis and Secretion by THP-1 Macrophages
Castilho, L. N., Chamberland, A., Boulet, L., Davignon, J., Cohn, J. S., & Bernier, L. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200308000-00015 · Cited by 10
Simvastatin Effects in Normo‐ and Hypercholesterolaemic Patients with Peripheral Arterial Occlusive Disease: A Pilot Study
Grodzińska, L., Starzyk, D., Bieroń, K., Goszcz, A., & Korbut, R. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_96603.x · Cited by 9
Alternate Day versus Once Daily Atorvastatin for Primary Prevention of (CHD) in Naïve Patients of Dyslipidemia
Ghia, C. J. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/7359.4096 · Cited by 8
Developmental Toxicity of the HMG‐CoA Reductase Inhibitor (PPD10558) in Rats and Rabbits
Faqi, A. S., Prohaska, D., López, R., & McIntyre, G. (2011) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20337 · Cited by 8
Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions
Copsel, S. N., Malek, T. R., & Levy, R. B. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.07.012 · Cited by 9
Statins as coronary vasodilators in isolated bovine coronary arteries—involvement of PGI2 and NO
Lorkowska, B., & Chłopicki, S. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.10.012 · Cited by 8
The Impact of Statin Therapy on the Survival of Patients with Gastrointestinal Cancer
Gachpazan, M., Kashani, H., Khazaei, M., Hassanian, S. M., Rezayi, M., Asgharzadeh, F., Ghayour‐Mobarhan, M., Ferns, G. A., & Avan, A. (2018) · Current Drug Targets · doi:10.2174/1389450120666181211165449 · Cited by 9
The use of statins in optimising reduction of cardiovascular risk: focus on fluvastatin
Corsini, A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.00154.x · Cited by 8
Self-citation
Drug Interactions Involving Immunosuppressive Agents
Anaizi, N. H. (2001) · Graft · doi:10.1177/152216280100400402 · Cited by 8
Treatment of Patients with Lipid Disorders in the Primary Care Setting: New Treatment Guidelines and their Implications
Keenan, J. M. (2003) · Southern Medical Journal · doi:10.1097/01.smj.0000061513.59902.6a · Cited by 8
Drug-drug Interactions and Statin Therapy
Trifirò, G. (2006) · Southern Medical Journal · doi:10.1097/01.smj.0000251414.22179.14 · Cited by 8
Influence of statin treatment in a cohort of patients admitted for COVID-19
Rey, J. R., Merino, J. L., Manjavacas, Á. M. I., Rodríguez, S. O. R., Castrejón‐Castrejón, S., Redondo, E. A., Pinedo, I. D. P., Márquez, D. T., Sánchez, A. S., Santana, B. R., et al. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.05.004 · Cited by 7
The mitochondrial redistribution of ENOS is regulated by AKT1 and dimer status
Sun, X., Caceres, S. M., Yegambaram, M., Lü, Q., Pokharel, M. D., Boehme, J. B., Datar, S. A., Aggarwal, S., Wang, T., Fineman, J. R., et al. (2024) · Nitric Oxide · doi:10.1016/j.niox.2024.09.009 · Cited by 7
Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation
Arnaboldi, L., Guzzetta, M., Pazzucconi, F., Radaelli, G., Paoletti, R., Sirtori, C. R., & Corsini, A. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.012 · Cited by 7
Self-citation
Improved in vitro dissolution parameters and in vivo hypolipidemic efficiency of atorvastatin calcium through the formation of hydrophilic inclusion complex with cyclodextrins
Hussein, A. K., Ibrahim, M. A., Amin, M. A., Ahmed, O. A. A., & Afouna, M. I. (2011) · Drug Development Research · doi:10.1002/ddr.20439 · Cited by 7
Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizons.
Mohammadi, M., Vaezi, M., Mirrahimi, B., & Hadjibabaie, M. (2016) · PubMed Central · Cited by 7
THE PROSPECT, PROMISES AND HINDRANCES OF STATIN BASE MOLECULES: LOOK BACK TO LOOK FORWARD
Affandi, M. M. R. M. M., Tripathy, M., & Majeed, A. B. A. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 7
Treatment of Dyslipidemia in Chronic Kidney Disease
Stefanović, V., & Milojković, M. (2004) · The International Journal of Artificial Organs · doi:10.1177/039139880402701002 · Cited by 7
THE ROLE OF NEEDLE IN FORMULATION OF pH SENSITIVE SWELLABLE MICROBEADS PREPARED WITH HYDROPHILIC POLYMERS FOR ATORVASTATIN AND THEIR CHARACTERIZATION STUDIES
Reddy, K. V. R., & Nagabhushanam, M. (2017) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2017v9i3.16952 · Cited by 7
Protocol for systematic review and meta-analysis: impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases
Sabeel, S., Motaung, B., Ozturk, M., Mukasa, S. L., Kengne, A. P., Blom, D. J., Sliwa, K. S., Nepolo, E., Günther, G., Wilkinson, R. J., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039034 · Cited by 7
On-flow enzymatic inhibitor screening: The emerging success of liquid chromatography-based assays
de Oliveira, P. C. O., Lessa, R., Ceroullo, M. S., Wegermann, C. A., & de Moraes, M. C. (2022) · Frontiers in Analytical Science · doi:10.3389/frans.2022.1004113 · Cited by 7
Low density lipoprotein receptor endocytosis in cardiovascular disease and the factors affecting LDL levels
Maurya, R., Bhattacharjee, G., Gohil, N., Khambhati, K., Shakhreliya, S., Bhatnagar, A., Singh, P., Ramakrishna, S., & Singh, V. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.09.010 · Cited by 7
An automated blood sampling system to measure lovastatin level in plasma and faeces
Wang, S., Ho, L., Yen, J., & Tsai, T. (2006) · Biomedical Chromatography · doi:10.1002/bmc.618 · Cited by 7
Statins Use and Risk for Brain Metastasis From Lung Cancer
Leigh, D., Eken, J., Beal, J., Ganti, A. K., & Sahmoun, A. E. (2010) · Cancer Investigation · doi:10.3109/07357907.2010.512592 · Cited by 7
Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1
Turner, E. C., & Kinsella, B. T. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m029314 · Cited by 7
Retracted
Development of Rapid and Validated RP-HPLC Method for Concurrent Quantification of Rosuvastatin and Aspirin form Solid Dosage Form
Attimarad, M., Alkadham, A., Almosawi, M. H., & Venugopala, K. N. (2018) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.52.1.17 · Cited by 7
The use of statins after solid organ transplantation
Holdaas, H. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.8.1537 · Cited by 7
Iatrogenic Rheumatic Syndromes in the Elderly
Quiceno, G. A., & Cush, J. J. (2007) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.12.010 · Cited by 7
Iatrogenic Rheumatic Syndromes in the Elderly
Quiceno, G. A., & Cush, J. J. (2005) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2005.02.004 · Cited by 7
Vascular inflammation and activation: new targets for lipid lowering*1
Aikawa, M. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90051-3 · Cited by 7
Erratum
(2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00070-x · Cited by 7
Comparative pharmacokinetic evaluation of nanoparticle-based vs. conventional pharmaceuticals containing statins in attenuating dyslipidaemia
Cordina, J., Ahmad, I., Nath, R., Rahim, B. A., Van, A., Al-Zuhairi, D., Williams, K. A., Pont, L., Cutler, R. L., Mehndiratta, S., et al. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03140-5 · Cited by 7
Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs
Bellosta, S., & Corsini, A. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2402493 · Cited by 8
Self-citation
Electroanalysis of Statin Drugs: A Review on the Electrochemical Sensor Architectures Ranging from Classical to Modern Systems
de Oliveira, A. M., Silva, R. M., da Silva, A. D., & Silva, T. A. (2024) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2024.2420820 · Cited by 6
Could statins be a new therapeutic option for antiphospholipid syndrome patients?
Erkan, D., & Pierangeli, S. S. (2013) · Expert Review of Hematology · doi:10.1586/ehm.13.8 · Cited by 6
Chemometric Analysis of Urinary Volatile Organic Compounds to Monitor the Efficacy of Pitavastatin Treatments on Mammary Tumor Progression over Time
Grocki, P., Woollam, M. D., Wang, L., Liu, S., Kalra, M., Siegel, A. P., Li, B., Yokota, H., & Agarwal, M. (2022) · Molecules · doi:10.3390/molecules27134277 · Cited by 6
Caffeic Acid-Grafted PLGA as a Novel Material for the Design of Fluvastatin-Eluting Nanoparticles for the Prevention of Neointimal Hyperplasia
Bellosta, S., Selmin, F., Magri, G., Castiglioni, S., Procacci, P., Sartori, P., Scarpa, E., Tolva, V., Rossi, C., Puoci, F., et al. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00693 · Cited by 6
Self-citation
Atorvastatin Calcium Ameliorates Cognitive Deficits Through the AMPK/Mtor Pathway in Rats with Vascular Dementia
Li, X., Chen, S., Zheng, G., Yang, Y., Yin, N., Niu, X., Yao, L., & Lv, P. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207326666230606114448 · Cited by 6
The effect of simvastatin treatment on endothelial cell response to shear stress and tumor necrosis factor alpha stimulation
Dick, M., MacDonald, K. N., Tardif, J., & Leask, R. L. (2015) · BioMedical Engineering OnLine · doi:10.1186/s12938-015-0057-x · Cited by 6
Cholesterol synthesis in central nervous system of rat is affected by simvastatin as well as by atorvastatin
Cibičková, Ľ., Hyšpler, R., Tichá, A., Cibicek, N., Palička, V., Čermáková, E., & Zadák, Z. (2008) · Die Pharmazie · doi:10.31083/ph.2008.8539 · Cited by 6
Role of Pharmacogenetics on Response to Statins: A Genotype-based Approach to Statin Therapy Outcome
Duman, İ. (2014) · Journal of Cardiology and Therapy · Cited by 6
Effects of local simvastatin on periosteal distraction osteogenesis in rabbits
Kahraman, O. E., Erdoğan, Ö., Namli, H., & Sencar, L. (2015) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2015.01.006 · Cited by 6
Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?
Liao, J. K. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0049-9 · Cited by 6
Influence of fluvastatin on cardiac function and baroreflex sensitivity in diabetic rats
Xie, F., Sun, C., Sun, L., Li, J., Chen, X., Che, H., Lu, G., Yang, B., & Ai, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.221 · Cited by 6
Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin
Baek, S. D., Jang, S.-J., Park, S., Ok, T. J., Leem, J., Lee, H., Park, S. J., & Kim, T. H. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.12.1634 · Cited by 6
New Treatments for Chagas Disease and the Relationship between Chagasic Patients and Cancers
Morais, V. M. D. O. S. (2014) · Cancer Research Journal · doi:10.11648/j.crj.s.2014020601.12 · Cited by 6
Statins and Breast Cancer: An Overview of the Current Situation
Moonindranath, S., & Shen, H. (2016) · Advances in Breast Cancer Research · doi:10.4236/abcr.2016.51002 · Cited by 6
Prevention of Cardiovascular Events with Pitavastatin is Associated with Increased Serum Lipoprotein Lipase Mass Level: Subgroup Analysis of the TOHO-LIP
Nagayama, D., Saiki, A., Watanabe, Y., Yamaguchi, T., Ohira, M., Sato, N., Kanayama, M., Moroi, M., Miyashita, Y., Shirai, K., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.62141 · Cited by 6
Cardiovascular Medications
Williams, S., Wynn, G. H., Cozza, K. L., & Sandson, N. B. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.6.537 · Cited by 5
Combined Administration of RG7652, a Recombinant Human Monoclonal Antibody Against PCSK9, and Atorvastatin Does Not Result in Reduction of Immune Function
Gelzleichter, T. R., Halpern, W., Erwin, R., Baruch, A., Leabman, M. K., Forrest, A. S., Satterwhite, C. M., Peng, K., Chilton, J. A., & Stevens, D. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu093 · Cited by 6
Endothelial cell response to hyperlipemia
Simionescu, M., Stancu, C. S., Costache, G., & Sima, A. V. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00252-5 · Cited by 6
Unconventional approaches to the prevention of cancer associated thrombosis
Zwicker, J. I. (2014) · Thrombosis Research · doi:10.1016/s0049-3848(14)50008-4 · Cited by 6
Development of Self-microemulsifying Drug Delivery System for Enhancing the Bioavailability of Atorvastatin
Jin, S.-J., Cho, W., Park, H.-J., Cha, K.-H., Park, J., Koo, J.-S., Wang, H.-S., Kim, J.-S., Kim, M., & Hwang, S. (2011) · Journal of Pharmaceutical Investigation · doi:10.4333/kps.2011.41.2.103 · Cited by 6
Efecto de las estatinas más allá del colesterol
Álvarez, F. H., Duque, M. G., Vargas, J. C. O., Velázquez, B. S., Moreno, V. A., Villegas, E., Sánchez‐Reyes, L., & Fanghänel, G. (2006) · Revista de Endocrinología y Nutrición · Cited by 6
Mechanisms of Lipoproteins and Reverse Cholesterol Transport in Atherosclerotic Cardiovascular Disease
Sucharski, H. C., & Koenig, S. N. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_12 · Cited by 6
In silico Analysis of the Polyphenolic Metabolites of Zea mays L. "Purple Corn" on HMG-CoA Reductase
Horna-Rodriguez Alexsandra, M., López- Gamboa July, A., Silva-Correa, C. R., Antonio, S.-G. W., & Gamarra-Sánchez, C. D. (2022) · Pharmacognosy Journal · doi:10.5530/pj.2022.14.70 · Cited by 5
STATINS AND THEIR INTERACTION WITH MODEL CELL MEMBRANES ACCORDING TO THE DATA OF NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
Анварович, Л. И., Galiullina, L. F., Musabirova, G., Aganova, O. V., Kim, Z. F., Aganov, A. V., & Klochkov, V. V. (2017) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2017-13-2-256-262 · Cited by 5
The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer
Schneiders, F. L., Huijts, C. M., Reijm, M., Bontkes, H. J., Verheul, H. M. W., de Gruijl, T. D., & van der Vliet, H. J. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.029 · Cited by 5
Influencia del tratamiento con estatinas en una cohorte de pacientes ingresados por COVID-19
Rey, J. R., Merino, J. L., Manjavacas, Á. M. I., Rodríguez, S. O. R., Castrejón‐Castrejón, S., Redondo, E. A., Pinedo, I. D. P., Márquez, D. T., Sánchez, A. S., Santana, B. R., et al. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.07.003 · Cited by 5
Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer
Takada, K., Kashiwagi, S., Iimori, N., Kouhashi, R., Yabumoto, A., Goto, W., Asano, Y., Tauchi, Y., Morisaki, T., Ogisawa, K., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-10631-w · Cited by 5
The influence of lovastatin on thrombomodulin gene expression in vascular endothelial cells--in vitro study.
Góralczyk, K., Soszyńska, K., Haus, O., Bielis, R., & Rość, D. (2009) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-009-0012-4 · Cited by 5
Development and Characterization of Atorvastatin Calcium Sustained Release Tablet Using Carbomer-974 and Hypromellose-15000 cps
Akbar, S., Bhatta, R., Rahman, M. A., Hossain, M. S., Bhuiyan, M. S., & Uddin, M. G. (2017) · Journal of Scientific Research · doi:10.3329/jsr.v9i2.30600 · Cited by 5
Can the Combination of Simvastatin and Melatonin Create a Synergistic Effect on Bone Regeneration?
Koç, O., Tüz, H. H., Ocak, M., Bilecenoğlu, B., Fırat, A., & Kaymaz, F. F. (2021) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2020.12.044 · Cited by 5
Estatinas: incidencia de efectos adversos
Spalvieri, M. P., & Oyola, M. E. (2011) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 5
Activation of Liver X Receptors Prevents Statin-induced Death of 3T3-L1 Preadipocytes
Madsen, L., Petersen, R. K., Steffensen, K. R., Pedersen, L. M., Hallenborg, P., Ma, T., Frøyland, L., Døskeland, S. O., Gustafsson, J.-Α., & Kristiansen, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800720200 · Cited by 5
Diverse effects of statins on endothelial cells?
Ferrara, D. E., & Pierangeli, S. S. (2005) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616260 · Cited by 5
Preparation and Dissolution of Polyvinylpyrrolidone(PVP)-Based Solid Dispersion Systems Containing Solubilizers
(2003) · Journal of Korean Pharmaceutical Sciences · doi:10.4333/kps.2003.33.1.007 · Cited by 5
Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans
Dominguez, J., Mendes, A. I., Pacheco, A. R., Peixoto, M. J., Pedrosa, J., & Fraga, A. G. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1266261 · Cited by 4
Therapeutic Potential of Simvastatin: Cellular Mechanism, Binding Energetics, and Resistance Developments
Verma, S., Malviya, R., Sundaram, S., Srivastava, S., Sridhar, S. B., Rab, S. O., & Singh, D. P. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266327892241223052456 · Cited by 4
The pharmacokinetics of single-dose oral atorvastatin and its metabolites support therapeutic use in cockatiels (Nymphicus hollandicus)
Mitchell, M., Guzman, D. S.-M., Knych, H. K. D., & Beaufrère, H. (2024) · American Journal of Veterinary Research · doi:10.2460/ajvr.24.03.0068 · Cited by 4
Effects of statins on male reproductive health: a systematic review of rodent studies and their potential implications to human male reproduction
Leite, G. A. A., Lazzari, V. M., Simão, V. A., & Sanabria, M. (2025) · Critical Reviews in Toxicology · doi:10.1080/10408444.2025.2504395 · Cited by 4
Pharmacokinetic Interactions of Rosuvastatin: A Review
Ahmad, M., Usman, M., & Sohail, M. F. (2012) · Journal of Pharmacy and Alternative Medicine · Cited by 4
Thiazolidinedione‐independent activation of peroxisome proliferator‐activated receptor γ is a potential target for diabetic macrovascular complications
Matsumura, T., Taketa, K., Shimoda, S., & Araki, E. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00182.x · Cited by 4
Combination lipid-lowering therapy in diabetes
Davidson, M. H. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0074-1 · Cited by 4
VALIDATION METHOD FOR MEASURING SIMVASTATIN IN HUMAN PLASMA BY HPLC-UV AND ITS APPLICATION IN STUDY SIMVASTATIN STABILITY IN PLASMA AND WORKING SOLUTION
Alakhali, K. M. (2014) · Asian Journal of Pharmaceutical and Clinical Research · Cited by 4

Authors: Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F.
Affiliations: University of Milan (IT)
University of Parma (IT)
Corresponding author: Corsini, Alberto
ORCID: Corsini, Alberto
Bellosta, Stefano
Baetta, Roberta
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 1999-12
Volume: 84
Issue: 3
Pages: 413-428
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/s0163-7258(99)00045-5
OpenAlex: W2045063002
Cited by: 796
References: 186
Citations by year: 2026: 5 · 2025: 6 · 2024: 27 · 2023: 19 · 2022: 17 · 2021: 25 · 2020: 17 · 2019: 14 · 2018: 21 · 2017: 30 · 2016: 30 · 2015: 27 · 2014: 35 · 2013: 31 · 2012: 38
FWCI: 5.97
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: statins, pharmacokinetics, pharmacodynamics, HMG-CoA reductase inhibition, mevalonate, pleiotropy, smooth muscle cell proliferation, macrophage cholesterol accumulation, atherosclerosis, drug interactions, CYP3A4, cyclosporine, rhabdomyolysis, myositis, pravastatin, fluvastatin, simvastatin, lovastatin, atorvastatin, cerivastatin
MeSH terms: Atorvastatin, Fluvastatin, Animals, Anticholesteremic Agents, Cell Division, Cytochrome P-450 Enzyme System, Drug Interactions, Fatty Acids, Monounsaturated, Heptanoic Acids, Humans, Indoles, Mevalonic Acid, Pyridines, Pyrroles, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Simvastatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

New insights into the pharmacodynamic and pharmacokinetic properties of statins

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks